A documented case by Mastorino et al. describes the development of lichen ruber planus during treatment for atopic dermatitis, raising the possibility that IL-4/IL-13 blockade may disrupt immune homeostasis in susceptible individuals, potentially unmasking or triggering LP via skewing toward Th1/Th17 dominance [55]. Here, IL13 is linked to atopic eczema.